Nasopharyngeal carcinoma study: Introduction and multidisciplinary perspective;Estudo do carcinoma de tipo nasofaringeo: Introdução e perspectiva multidisciplinar

Acta Medica Portuguesa

Volumn 21, Issue 1-3, 2008, Pages 273-284

  Breda, Eduardo ^a   Catarino, Raquel ^a   Coelho, Ana ^a   Sousa, Hugo ^a   Medeiros, Rui ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMICAL VARIATION; CRANIOPHARYNGIOMA; EMBRYO DEVELOPMENT; HUMAN; NASOPHARYNX CARCINOMA; ONTOGENY; PATHOPHYSIOLOGY; REVIEW;

CARCINOMA; HUMANS; INTERDISCIPLINARY COMMUNICATION; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX;

EID: 51349083239     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. DAMÁSIO A: O Sentimento de Si, Publ Europa-America Lda 2000;365-6
2. FOERSTER H: Construyendo una realidad in La realidad inventada-Paul Watzlawick Gedisa eds 1998;38-54
3. POQUELIN JB (Molière): Le Bourgeois gentilhomme.1670
4. BEASLEY P: Anatomy of the pharynx and oesophagus - Scott-Brown's Otolaryngol fifth edition 1987;cap10;245-283
5. BELTRAMELLO A, PUPPINI G, EL-DALATI G, GIRELLI M: Fossa Navicularis Magna. Am J Neuroradiol 1998;19:1796-8
6. SADLER TW: Langman's Medical Embryology seventh edition 1995
7. Gray's Anatomy thirty-seventh edition, edited by WILLIAM PL, WARWIC R, DYSON M et al: 1993;pp161-8
8. ARCY LB: The craniopharyngeal canal rewied and reinterpretated. Anat res 1950;106:1-16
9. MARSOT-DUPOUCH K, SMOKER W, GRAUER W: A rare Expression of neural crest disorders: an intrasphenoidal development of the anterior pituitary gland. Am J Neuroradiol 2004;25:285-8
10. BARKOVICH AJ, CHUANG SH, NORMAN D: Mr of neuronal migration anomalies. Am J Neuroradiol 1987;8:1009-17
11. EKINCI G, KILIÇ T, BALTACIOGLU I et al: Transphenoidal (large craniopharyngeal) canal associated with a normally functioning pituitary gland and nasopharyngeal extention, hyperprlactinemia and hypothalamic hamartroma. Ajr 2003;180:76-7
12. ESTEBAN F,RUIZ-AVILA I, VILCHEZ R et al: Ectopic pituitary adenoma in the sphenoid causing Nelson's syndrome. J Laryngol Otol 1997;111:565-7
13. CANKAL F, UGUR H.C., TEKDEMIR I., ELHAN A et al: Fossa Navicularis: Anatomic Variation at the Skull Base. Clin Anat 2004;17:118-122
14. DIEWERT VM: A morphometric analysis of craniofacial growth and changes in spacial relations during secondary palatal development in human embryos and fetuses. Am J Anat 1983; 167(4);494-522
15. ANTUNES MT: Enciclopédia luso-brasileira de cultura, Verbo ed. 1976;18:pp 958/9
16. a edition, edited by Peter L Williams and Roger Warwick, 1980;pp126-7
17. BULL JW: Tentorium Cerebelli. Proc.Royal Soc Med 1969;62:1301-10
18. JEFFERY N: Differential regional brain grow and rotation of the prenatal human tentorium cerebelli. J Anat 2002;200:135-144
19. MASTERS AV, FALK D, GAGE TD: Effects of age and gender on the location and orientation of the foramen magnum in rhesus macaque (macaca mulatta), Am J Physical Antropol 2005;86(1):75-80
20. JEFFERY N: Cranial base angulation and growth of the human pharynx, The Anatomical Reccord part A Disc. Mov Cell Evol Biol 2005;284(1):491-9
21. ONDREY FG,WRIGHT SK: Ballenger's Otrhinolaryngology Head and Neck Surger y sixteenth ed 2003;chapter 60
22. NEMZEK WR, BRODIE HI, HECHT ST et al: MR, CT and Plain film Imaging of the Developing Skull Base in Fetal Specimens. Am J Neuroradiol 2000;21:1699-1706
23. ROUVIÉRE H, DELMAS A. Anatomie Humaine descriptive, topographique et foncionelle, 1° edition Tome I 1967
24. NIELSEN S, KING LS, CHRISTENSEN MB et al: Aquoporin in complex tissues II. Subcellulardistribuition in respiratory and glandular tissues of rat. Am J Physiol Cell physiol 1997;273:C1549-61
25. DENKER BM, SMITH BL, KUHAJDA FP et al: Identification, purification and parcial characterization of a novel M 28000 integral membrane protein from erythrocytes and renal tubules. J Biol Chem 1988;271;25079-82
26. MATSUZAKI T, TAJIKA Y, TSERENTSOODOL N et al: Aquoporins:a water channel family. Anat Scien Int 2002;77,85-93
27. KIVONO H, FUKUYAMA S: NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004;4(9):699-710
28. STAL PS, LINDMAN R: Charactersation of human soft palate muscles with respect to fibre types, myosin and capillary supply. J Anat 2000;197:275-290
29. BOURIHIS J, SCHWAAB G: Cancer du Nasophrynx (cavum). Enycl Méd Chir (Elsevier,Paris), Oto-rhino-laryngologie 1999;20-590-A-10
30. KUANG GQ, MOLG, YANG RN: Investigation of the site of origin to develop micro-focal nasopharyngeal carcinoma. Zhonghua Zhong liu Za Zhi 2005;27(8):505-6
31. SHAM JS, CHEUNG YK, CHOY D et al: Nasopharyngeal Carcinoma: CT evaluation of patterns of tumor spread. AJNR 1999;12:265-270
32. MENDENHALL WM: Nasopharynx. In Millio RR and Cassisi NJ eds. Management of Head and Neck Cancer, A Multidisciplinary Approach. Philadelphia: J. B. Lippincott Company (2° edition) 1994;599:626
33. CHAN SH, DAY NE, KUNARATNAM N et al: HLA and Nasopharyngeal Carcionoma in Chinese - a further study. Int J Cancer 1983;32;171-6
34. COELHO A, MATOS A, CATARINO R et al: Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma. Gynecol Oncol 2005;96(3):760-4
35. COSTA S, PINTO D, MORAIS A et al: Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population. Prostate 2005;64:246-252
36. FREITAS-SILVA M, PEREIRA D, COELHO C et al: Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet 2004;155(1):42-6
37. RIBEIRO R, LOPES C, MEDEIROS R: Leptin and prostate: implications for cancer prevention - overview of genetics and molecular interactions. Eur J Cancer Prev 2004;13(5):359-68. Review
38. MEDEIROS R, SOARES R, VASCONCELOS A et al: Glutathione S-transferase genotype GSTM1 as a predictor of elevated angiogenic phenotype in patients with early onset breast cancer. Angiogenesis 2004;7(1):53-8
39. PINTO D, VASCONCELOS A, COSTA S et al: HER2 polymorphism and breast cancer risk in Portugal.Eur J Cancer Prev 2004;13(3):177-181
40. CRAVEIRO R, COSTA S, PINTO D et al: Related Articles, Links TP73 alterations in cervical carcinoma. Cancer Genet Cytogenet 2004;150(2):116-121
41. RIBEIRO R, VASCONCELOS A, COSTA S et al: Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 2004;59(3):268-274
42. MEDEIROS R, VASCONCELOS A, COSTA S et al: Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 2004;202(3):330-5
43. MEDEIROS R, VASCONCELOS A, COSTA S et al: Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms. Prostate 2004;58(4):414-420
44. MEDEIROS R, PEREIRA D, AFONSO N et al: Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome.Int J Clin Oncol 2003;8(3):156-161
45. FERREIRA PM, MEDEIROS R, VASCONCELOS A et al: Association between CYP2E1 polymorphisms and susceptibility to prostate cancer.Eur J Cancer Prev 2003;12(3):205-211
46. MEDEIROS R, VASCONCELOS A, COSTA S et al: Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer. Cancer Genet Cytogenet 2003;141(2):91-6
47. COSTA S, MEDEIROS R, VASCONCELOS A et al: A slow acetylator genotype associated with an increased risk of advanced cervical cancer. J Cancer Res Clin Oncol 2002;128(12):678-82 Epub 2002 Nov 12
48. MEDEIROS R, MORAIS A, VASCONCELOS A et al: Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients. Cancer Lett 2003;189(1):85-90
49. MEDEIROS RM, MORAIS A, VASCONCELOS A et al: Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clin Cancer Res 2002;8(11):3433-7
50. MEDEIROS R, MORAIS A, VASCONCELOS A et al: Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells. Prostate. 2002;53(1):88-94
51. MEDEIROS R, MORAIS A, VASCONCELOS A et al: Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer.Eur J Cancer Prev 2002;11(4):343-50
52. CATARINO RJ, BREDA E, COELHO V et al: Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma.. Head Neck 2006;28(7):603-8
53. SOUSA H, SANTOS AM, CATARINO R et al: Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development. Eur J Cancer Prev 2006;15(4):362-6
54. HO JHC: Genetic and environmental factors in naspharyngeal carcinoma (NPC).In W Nakahara, Nihioka, Hiayama, Y Ito Eds. Recents Advances in Human Tumor Virology and Immunology. Baltimore, University Park Press 1971;275-295
55. PEARSON G, WEILAND LH, NEEL B et al: Aplication of Epstein-Barr Serology to the Diagnosis of North American Nasopharyngeal Carcinoma. Cancer 1983;51;260-268
56. LUNG ML, CHAN KH, LAM WP et al: In-situ Detection of Epstein-Barr Virus Markers in Nasopharyngeal Carcinoma Patients. Oncol 1989;46;310-7
57. WEISS LM, MOVAHED LA, BUTLER AE et al: Analysis of Lymphoepitelioma and Lymphoepithelioma-like Carcinomas for Epstein-Barr Viral Genomes by in-situ Hybridization. Am J Surg Pathol 1989,13(8):624-631
58. EPSTEIN MA, BARR YM: Virus particules in cultured lymphoblats from Burkitt's Lymphoma. Lancet 1964;1:702-3
59. TANNER JE, WEI MX, ALFIERI C et al: Antibody and antibody-dependent Cellular Citotoxoc Reponses against the BamHI A Righward Open-reading Frame-1 Protein of EBV and EBV-Associated disorders. J Infectious Dis 1997;175:38-46
60. NIEDOBITEK G, AGATHANGGELOU A, NICHOLS JM: Epstein-Barr virus infection and the pathogenesis of the nasopharyngeal carcinoma: viral gene expression, tumor cell phenotype, and the role of the lymphoid stroma. Sem Cancer Biol 1996;7;165-174
61. KINGMA DW, WEISS WB, JAFFE ES et al: M-Epstein Virus Latent Membarne Protein-1 Oncogene Delections:correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas, Blood 1996;88:242-251
62. SCHAEFER B, WOISETSCHLAEGER M, STROMINGER J et al: Exclusive expression of Epstein-Barr virus nuclear antigen I in Burkitt lymphoma arise from a third promoter distinct from the promoters used in latently infected lymphocites. Proc Natl Acad Sci USA 1991;8:6550
63. FAHRAEUS R, FU H, ERNBERG I et al: Expression of Epstein-Barr virus-encoded protein in naspharyngeal carcinoma. Int J Cancer 1988;42:329
64. HAMILTON-DUTOIT S, REA D, RAPHAEL M et al: Epstein-Barr virus-latent gene expression and tumor cell phenotype in adquired immunodeficiency syndrome phenotipe with three distinct patterns of viral latency. Am J Pathol 1993;143:1072
65. YATES J: A cis-acting element from de Eptsein-Barr virus genome that permits stable replication of recombinants plasmids in latently infected cells. Proc Natl Acad Sci USA 1984;81:3806-10
66. HAMMERSCHMIDT W, SUGDEN B: Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocites. Nature 1989;340:393-7
67. KIEFF E: Epstein-Barr virus and its replication. Fields BN, Knipe DM, Howley PM, eds Fields Virology, Lippincott-Raven, Philadelphia 1996; 2343-96
68. ZIMBER U, ADLDINGER HK, LENOIR GM et al: Geographical prevalence of two types of Epstein-Barr virus. Virol 1986;154:56-66
69. MILLER CL: Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 1995;2:155-166
70. WANG D, LEIBOWITS D, WANG F et al: E Epstein-Barr viruslatent infection membrane protein alters the human Blymphocytes phenotype: deletion of the aminus terminus abolishes activity. J Virol 1988;62:4173-84
71. DAWSON CW, RICKINSON AB, YOUNG LS: Epstein-Barr virus latent membrane protein inibits human eppithelial cell diferentiation. Nature 1990;344;777-780
72. ROWE M, PENG-PILON M, HUEN DS et al: Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cellspecific reponse thatisdelayed relative to NF-kb activation and to induction of cell surface markers, J Vrol 1994;8:122-131
73. SANDJEV K, GRATAMA JW, MUCH M, et al.: Sequence Analysis of Epstein-Barr Virus Latent Membrane Protein-1 Gene and Promoter Region: Identification of Four Variants among Wildtype EBV isolates. Blood 1997;90:323-330
74. MURONO S, YOSHIZAKI T, TANAKA S et al: Detection of Epstein-Barr Virus in Nasopharyngeal Carcinoma by in Situ Hybridization and Polymerase Chain Reaction; Laryngoscope 1977;107:523-6
75. BREDA E, QUEIRÓS A, MONIZ C et al: Detecção do Vírus Epstein-Barr (EBV) no Carcinoma Indiferenciado da Nasofaringe em Portugal - Zona Norte. Rev Port 2001;39(4):363-8